In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
All content for Talking Rheumatology Research is the property of British Society for Rheumatology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby
Talking Rheumatology Research
16 minutes
2 years ago
Ep 33. Trainee Publishing Programme 2023: Dr Lauren Huckerby
What evidence is there for effective transitional care in young people with chronic pain, and what should ideal transitional care look like? Dr Lauren Huckerby joins Dr Diederik De Cock to discuss her recent systematic review - one of the winning papers from the 2023 Rheumatology Advances in Practice Trainee Publishing Programme. Dr Huckerby is a paediatric and adolescent rheumatology registrar at Royal Manchester Children’s Hospital. Read the winning paper: Growing up with chronic pain: a sy...
Talking Rheumatology Research
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active refractory Behçet’s. Listen now to hear the findings and what this means for future clinical practice! Further reading: You can read this article [https://doi.org/10.1093/rheumatology/keae585] in Rheumatology. Thanks for listening to T...
